(S)-MRTX-1719 is the S-enantiomer of Navlimetostat and acts as a PRMT5/MTA complex inhibitor with an IC50 value of 7070 nM, enabling selective modulation of arginine methylation, epigenetic regulation, and transcriptional control, (S)-MRTX-1719 is widely applied in cancer epigenetics research to investigate PRMT5-dependent tumor growth and therapeutic vulnerabilities.
Molecular Weight:
464.88
Purity:
99.82%
CAS Number:
[2630904-44-6]
Formula:
C23H18ClFN6O2
Target:
Histone Methyltransferase
T62960
* VAT and and shipping costs not included. Errors and price changes excepted